INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Narrative review / 2020

A stepwise management approach based on lifestyle interventions and lipid-lowering therapy is proposed for low-CVD-risk individuals with elevated LDL-C.

Existing guidelines show considerable inconsistency regarding the management of patients at low overall cardiovascular disease (CVD) risk who have persistently elevated LDL-C. Authors propose a step-by-step practical approach for individuals with low (< 1%) 10-year CVD risk and elevated LDL-C (> 140 mg/dL, 3.6 mmol/L). The strategy is based on adherence to lifestyle interventions, with stepwise management including lipid-lowering therapy if non-adherent, targeting LDL-C levels < 115 mg/dL (3.0 mmol/L). The authors note further studies are needed to determine the long-term efficacy, safety, and cost-effectiveness of this approach.

Study type
Narrative review and proposal
Who was studied
Individuals with low (< 1%) 10-year CVD risk and elevated LDL-C (> 140 mg/dL)
What was measured
Management of cardiovascular risk and LDL-C target levels (< 115 mg/dL)

THE PAPER

LDL-C: lower is better for longer-even at low risk.

Penson PE, Pirro M, Banach M. BMC Med, 2020.

PubMed 33032586 ↗DOI 10.1056/nejmra1806939 ↗

Heart & arteries

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.